Vanguard Asset Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCRX
Vanguard Asset Management's PCRX Position: Q3 2026 in Review
Vanguard Asset Management held its Pacira BioSciences (PCRX) position steady in Q3 2026 at 26,450 shares worth $663K. The position accounts for ﹤0.01% of the portfolio, ranked #2060.
Vanguard Asset Management first reported a position in PCRX in Q1 2026 and has held it in 3 quarters since. The position peaked at $671K in Q2 2026. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.
- Vanguard Asset Management held 26,450 shares of Pacira BioSciences worth $663K as of Q3 2026.
- Vanguard Asset Management left its Pacira BioSciences share count unchanged in Q3 2026.
- Pacira BioSciences made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #2060 holding.
- Vanguard Asset Management first reported a position in Pacira BioSciences in Q1 2026 and has held it in 3 quarters since.
- Vanguard Asset Management's Pacira BioSciences position peaked at $671K in Q2 2026.
- 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.
Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.